Clinical Trial Update: SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009) [NA]

View source ↗

Summary

This clinical trial entry describes a study evaluating sentinel lymph node dissection (SLND) versus no SLND in cT1 invasive lung adenocarcinoma with ground-glas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: Carcinoma, Non-Small-Cell Lung | NA | Status: RECRUITING